Article Versions Notes

Hampe CS, Wesley J, Lund TC, Orchard PJ, Polgreen LE, Eisengart JB, McLoon LK, Cureoglu S, Schachern P, McIvor RS. Mucopolysaccharidosis Type I: Current Treatments, Limitations, and Prospects for Improvement. Biomolecules. 2021; 11(2):189. https://doi.org/10.3390/biom11020189

Hampe, Christiane S., Jacob Wesley, Troy C. Lund, Paul J. Orchard, Lynda E. Polgreen, Julie B. Eisengart, Linda K. McLoon, Sebahattin Cureoglu, Patricia Schachern, and R. Scott McIvor. 2021. "Mucopolysaccharidosis Type I: Current Treatments, Limitations, and Prospects for Improvement" Biomolecules 11, no. 2: 189. https://doi.org/10.3390/biom11020189

Hampe, C. S., Wesley, J., Lund, T. C., Orchard, P. J., Polgreen, L. E., Eisengart, J. B., McLoon, L. K., Cureoglu, S., Schachern, P., & McIvor, R. S. (2021). Mucopolysaccharidosis Type I: Current Treatments, Limitations, and Prospects for Improvement. Biomolecules, 11(2), 189. https://doi.org/10.3390/biom11020189